Novozymes AS share price logo

Novozymes AS

NASDAQ: NVZMY

Large Cap

$58.21

+0.38

(+0.66%)

as on

Novozymes AS Stock Performance

as on May 21, 2026 at 6:58 am IST

  • Day's Low

    Day's High

    $56.82
    $58.52
    downward going graph

    2.39%

    Downside

    0.53%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Novozymes AS share price movements today

Previous Close
$57.83
Open
$57.69
Volume
36.6K
Day's Low - High
$56.82 - $58.52

Novozymes AS Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Novozymes AS Stock Fundamentals & Key Indicators

Check Novozymes AS market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$26.9B

EPS (TTM)

2.4888

Dividend Yield

148.00%

PE Ratio (TTM)

38.74

Industry PE ratio

25.267333333333333

PEG Ratio

1.9772

Return On Equity TTM

5.39%

Novozymes AS Stock Valuation

Track how Novozymes AS P/E has moved over time to understand its valuation trends.

Novozymes AS in the last 5 years

  • Overview

  • Trends

Lowest (24.76x)

September 30, 2023

Industry (25.27x)

May 20, 2026

Today (38.74x)

May 20, 2026

Highest (47.01x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 38.74x

Novozymes AS vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Novozymes AS with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$26.9BNA38.7414.21%
HOLD$70.1B14.63%33.6812.80%
BUY$236.2B69.75%33.920.44%
BUY$74.7B5.82%29.0610.86%
BUY$65.0B-1.78%30.7816.91%

Novozymes AS Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
674
6,831
7,350
7,462
7,464
1,077
1,018
7,921
996
1,137
Gross Profit
363
2,860
3,078
4,571
1,042
594
544
4,046
558
644
Operating Income
1,531
503
503
1,364
435
265
192
1,456
187
272
EBITDA
1,188
1,125
1,125
2,581
435
275
219
2,474
270
424
Interest Expense
120
18
24
137
37
19
15
111
16
8
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
923
335
335
1,219
327
244
174
1,276
152
261
Income Tax Expense
228
97
97
317
85
58
37
249
29
58
Net Income
102
238
256
901
241
186
136
1,026
-765
202
Net Profit Margin
15.16%
3.49%
3.49%
12.08%
3.24%
17.26%
13.43%
12.95%
-76.78%
17.79%

Novozymes AS Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
2,004
2,309
2,192
2,137
2,290
2,272
2,497
2,621
4,010
4,157
Gross Profit
1,151
1,337
1,257
1,182
1,283
1,310
1,362
1,423
1,893
2,241
Operating Income
3,946
4,047
4,070
4,039
3,652
4,007
4,629
3,976
659
882
EBITDA
4,886
5,193
5,037
5,067
4,818
5,400
6,115
5,471
8,071
1,386
Interest Expense
31
27
13
86
63
102
102
23
76
9
Depreciation
-
1,040
1,011
1,182
1,266
1,416
1,457
1,389
544
574
Income Before Tax
3,881
3,876
3,936
3,799
3,521
3,924
4,556
3,909
417
743
Income Tax Expense
831
756
709
644
695
779
870
870
111
153
Net Income
432
495
491
469
461
478
522
442
319
583
Net Profit Margin
21.57%
21.46%
22.42%
21.94%
20.16%
21.04%
20.94%
16.89%
7.98%
14.04%

Novozymes AS Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
238
238
901
241
186
136
137
122
202
Operating Cash Flow
1,969
1,969
1,833
491
106
320
3,458
328
169
Investing Cash Flow
-204
-204
-539
-144
-38
-1,541
-1,591
-226
-94
Financing Cash Flow
-89
-1,392
-1,229
-329
-102
1,309
-2,212
-102
-26
Change in Cash
63
414
-
19
-30
78
-348
-6
46

Novozymes AS Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
3,120
3,227
3,155
2,826
3,145
3,686
3,024
305
583
Operating Cash Flow
4,063
3,679
3,196
4,355
4,062
4,006
4,152
1,019
1,221
Investing Cash Flow
-1,668
-1,392
-561
-1,524
-2,747
-2,672
-2,133
-199
-1,970
Financing Cash Flow
-2,815
-2,167
-2,644
-2,314
-1,586
-1,250
-1,889
-703
753
Change in Cash
-442
91
-12
470
-218
78
75
130
-4

Insights on Novozymes AS

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -765.2M → 202.37M (in $), with an average increase of 478.1% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 996.6M → 1.13B (in $), with an average increase of 12.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Ecolab, Inc. has given 36.2% return, outperforming this stock by 26.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Linde plc Ordinary Shares has given 10.1% return, outperforming this stock by 26.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, NVZMY stock has moved down by -16.1%

About Novozymes AS

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; ethanol for liquefaction, saccharification, fermentation, and fiber conversion; and renewable diesel. In addition, it provides dishwashing, home cleaning, laundry, medical, and industrial and institutional cleaning services; gastrointestinal, immune, mental, women's, children's cardiometabolic, and oral human health solutions. Further, the company offers corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; silage, diary and beef cattle, poultry, swine, aquaculture solutions; pet care solutions; leather and textiles solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions; and distilling, oils and fats, sustainable plastic solutions. Additionally, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S is headquartered in Lyngby, Denmark.
OrganisationNovozymes AS
HeadquartersBiologiens Vej 2, Lyngby, Denmark, 2800
IndustrySpecialty Chemicals
CEOMs. Ester Baiget
E-voting on sharesClick here to vote

Key Management of Novozymes AS

Name

Title

Mr. Rainer Lehmann

Executive VP & CFO

Mr. Anders Lund

Chief Operating Officer

Mr. Tue Micheelsen

President of Novonesis North America & Head of Global Consumer Health

Mr. Andrew Taylor

Executive Vice President of Food & Beverage Biosolutions

Ms. Ester Baiget

President & CEO

Mr. Claus Crone Fuglsang

Chief Scientific Officer

Mr. Tobias Cornelius Bjorklund

Head of Investor Relations

Mr. Morten Enggaard Rasmussen

Executive Vice President of People & Stakeholder Relations

Ms. Tina Sejersgaard Fano

Executive Vice President of Planetary Health Biosolutions

Mr. Henrik Joerck Nielsen

EVP of Human Health Biosolutions and Strategy & Integration

FAQs

What is Novozymes AS share price today?

Novozymes AS share price today is $58.21 as on at the close of the market. Novozymes AS share today touched a day high of $58.52 and a low of $56.82.

What is the 52 week high and 52 week low for Novozymes AS share?

Novozymes AS share touched a 52 week high of $ on and a 52 week low of $ on . Novozymes AS stock price today i.e. is closed at $58.21,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Novozymes AS's market capitalisation today?

Novozymes AS market capitalisation is $0.03T as on .

How to invest in Novozymes AS Stock (NVZMY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Novozymes AS on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Novozymes AS Shares that will get you 0.0258 shares as per Novozymes AS share price of $58.21 per share as on May 21, 2026 at 1:28 am IST.

What is the minimum amount required to buy Novozymes AS Stock (NVZMY) from India?

Indian investors can start investing in Novozymes AS (NVZMY) shares with as little as ₹96.81 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹968.10 in Novozymes AS stock (as per the Rupee-Dollar exchange rate as on ). Based on Novozymes AS share’s latest price of $58.21 as on May 21, 2026 at 1:28 am IST, you will get 0.1718 shares of Novozymes AS. Learn more about fractional shares .